|
|
|
±è°æ´ö ( Kim Gyung-Duck ) - µ¿¾ç´ëÇб³ °£È£Çаú
Á¤º¹·Ê ( Chung Bok-Yae ) - °æºÏ´ëÇб³ °£È£´ëÇÐ ±è°æÇý ( Kim Kyug-Hae ) - ±èõ´ëÇб³ °£È£Çаú º¯Çý¼± ( Byun Hye-Sun ) - ¼ö¼º´ëÇб³ °£È£Çаú ÃÖÀºÈñ ( Choi Eun-Hee ) - ¿µ³²ÀÌ°ø´ëÇб³ °£È£Çаú
|
|
Abstract
|
|
|
|
Purpose: This study was to compare climacteric symptoms and cognitive impairment in breast cancer survivors (n=51) and healthy women (n=51).
Methods: This study was conducted from January 4th, 2012 to February 16th, 2012. We individually matched healthy women to breast cancer survivors based on age and education, and assessed a questionnaire regarding climacteric symptoms and cognitive impairment. Data were analyzed by using ¥ö©÷, t-test, and Pearson correlation with the SPSS/Win 12.0 program.
Results: The average score for the climacteric symptoms (19.71) was significantly different (t=-2.78, p=.006) to the average for the breast cancer survivors (15.53). The average cognitive impairment score for the breast cancer survivors (86.37) was significantly different (t=-2.45, p=.016) to the average score for the healthy women (67.92). The climacteric symptoms score showed a significant relationship with cognitive impairment.
Conclusion: These results support that adjuvant chemotherapy and anti-hormone therapy are associated with climacteric symptoms and adverse cognitive effects in breast cancer survivors.
|
|
KeyWords
|
|
À¯¹æ¾Ï »ýÁ¸ÀÚ, °»³â±â Áõ»ó, Àαâ±â´É
Breast Neoplasms, Survivors, Climacteric, Symptoms, Cognitive Disorder
|
|
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
|
|
|
|
µîÀçÀú³Î Á¤º¸
|
|
|
|
|
|